quant Healthcare Fund · Regular · Growth
NAV
₹16.2977
as of 17 Jun 2026
Expense Ratio
2.42%
AUM
₹344 Cr
Lumpsum returns (CAGR)
- 1Y
- +5.56%
- 3Y
- —
- 5Y
- —
- Since Inception
- +18.22%
SIP returns (XIRR)
- 1Y
- +14.55%
- 3Y
- —
- 5Y
- —
- Since Inception
- +10.87%
Beat the benchmark — ₹500/month SIP
Same SIP in this fund vs the benchmark index
This fund
₹20,082
Benchmark
₹18,795
+₹1,287 extra wealth vs the benchmark index
Backtest this SIP yourselfSIP since inception — what ₹500/month became
Real NAV backtest from day one
₹17,500
Invested
₹20,082
Value today
9.8%
XIRR (p.a.)
₹500/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹1,000 lumpsum at launch — value today
Invested on the fund's first NAV date
₹1,000
Invested
₹1,613
Value today
17.9%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹8,17,420
Value today
-15.6%
vs lumpsum
Direct lumpsum would have beaten STP by 15.6% — but STP reduced timing risk
Model your own STP with real NAVRisk Metrics
Trailing 1 year, annualised-0.05
Sharpe Ratio
+0.01
Alpha
0.47
Beta
-0.05
Sortino
17.86%
Std Dev
-19.03%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 30 Apr 2026- Pharmaceuticals & Biotechnology49.00%
- Food Products9.00%
- Healthcare Services9.00%
- Insurance8.00%
- Telecom - Services7.00%
- Retailing4.00%
Each sector links to the mutual funds most exposed to it.
Thinking about quant Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Zydus Wellness Ltd9.27%
- 2Anthem Biosciences Limited9.17%
- 3Aster Dm Healthcare Limited8.90%
- 4Sms Pharmaceuticals Limited8.86%
- 5Sequent Scientific Limited8.62%
- 6Alivus Life Sciences7.27%
- 7Hfcl Limited7.14%
- 8Pfizer Ltd6.42%
- 9Aurobindo Pharma Limited5.15%
- 10Icici Prudential Life Insurance Co Ltd4.35%
Investment Objective
quant Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
quant Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by quant Mutual Fund. The fund has been operational for over 2 years. It manages assets worth ₹344 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY HEALTHCARE INDEX TRI. The current expense ratio is 2.42%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations